通过连接体设计和新的双核铜复合体,改变DNA氧化的选择性从脱氧化到关氨酸
Lei Li1, Kenneth D Karlin, Steven E Rokita
1Department of Chemistry, The Johns Hopkins University, Baltimore, Maryland 21218, USA.
Journal of the American Chemical Society
|January 13, 2005
概括
一种新的双核铜复合体选择性地氧化DNA中的关氨酸,形成独特的衍生物. 这种铜复合体对DNA骨干损伤的核基基修饰具有很高的选择性.
科学领域:
- 生物有机化学 生物有机化学
- DNA损伤和修复的过程
- 化学生物学 化学生物学
背景情况:
- 众所周知,铜复合物与DNA相互作用,往往导致链分裂.
- 了解铜介导DNA氧化的特定机制对于开发有针对性的治疗或诊断工具至关重要.
研究的目的:
- 为了研究一个特定的双核铜复合体,CuII2 (((PD'O) ((H2O) 2) 3+对单链DNA的反应性.
- 描述DNA上形成的氧化产物,并评估反应的选择性.
主要方法:
- 用双核铜复合体处理单链DNA,在3 - 墨卡托酸和二氧化的存在下.
- 通过piperidine处理检测DNA修饰.
- 化学表征和纳米喷雾电离质谱学对改性寡氧核酸的化学表征.
主要成果:
- 双核铜复合体在单链DNA中选择性地促进了瓜氧化.
- 观察到的关氨酸衍生物包括2,6-氨基-5-形式胺基-4-氧胺基 (+18 amu) 和潜在的5,8-二氧-7,8-二氨基 (+34 amu).
- 观察到最小的自发DNA链分裂,表明脱氧化氧化程度低.
结论:
- 双核铜复合体对关氨酸氧化表现出了显著的选择性,而不是去氧化氧化.
- 与PD'OH连接体形成的特定的二铜 (水) 氧物种可能决定了这种选择性.
- 这一发现为设计用于向DNA修改的铜复合体提供了洞察力.
相关概念视频
Base Excision Repair
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Oxidation and Reduction of Organic Molecules
Energy production within a cell involves many coordinated chemical pathways. Most of these pathways are combinations of oxidation and reduction reactions, which occur at the same time. An oxidation reaction strips an electron from an atom in a compound, and the addition of this electron to another compound is a reduction reaction. Because oxidation and reduction usually occur together, these pairs of reactions are called redox reactions.
The removal of an electron from a molecule, results in a...
The removal of an electron from a molecule, results in a...
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.


